BiomX News

BiomX Analyst Ratings

BenzingaMay 28 11:34 ET

BiomX Buy Rating Affirmed on Clinical Progress and Strategic Acquisition

TipRanksMay 22 06:46 ET

BiomX Analyst Ratings

BenzingaMay 21 11:37 ET

BiomX's Strategic Progress and Positive Trials Fuel Buy Rating

TipRanksMay 21 10:55 ET

BiomX Analyst Ratings

BenzingaApr 22 06:31 ET

Biomx Inc. at a Crossroads: Shareholder Approval Required for Convertible Securities Amid Liquidity Concerns

TipRanksApr 5 02:00 ET

Analysts Are Bullish on These Healthcare Stocks: BiomX (PHGE), Daré Bioscience (DARE)

TipRanksApr 3 14:50 ET

BiomX Analyst Ratings

BenzingaApr 3 11:38 ET

BiomX's Robust Financial Health and Promising Clinical Advancements Bolster Buy Rating

TipRanksApr 3 10:35 ET

BiomX Analyst Ratings

BenzingaMar 7 07:04 ET

BiomX Buy Rating Justified by Merger Synergy, Enhanced Financial Stability, and Promising Clinical Trials

TipRanksMar 7 06:27 ET

Analysts' Opinions Are Mixed on These Healthcare Stocks: CytomX Therapeutics (CTMX), BiomX (PHGE) and Moderna (MRNA)

TipRanksDec 1, 2023 06:30 ET

Buy Rating Affirmed for BiomX as BX004 Shows Strong Efficacy in Phase 2a Cystic Fibrosis Study

TipRanksNov 30, 2023 06:49 ET

Promising Clinical Trials and Financial Stability Bolster BiomX's Buy Rating: An Analysis by Michael Higgins

TipRanksNov 15, 2023 06:45 ET

HC Wainwright & Co. Reiterates Buy on BiomX, Maintains $7 Price Target

BenzingaNov 14, 2023 11:18 ET

BiomX Analyst Ratings

BenzingaNov 14, 2023 11:16 ET

Analysts Offer Insights on Healthcare Companies: BiomX (PHGE), Quoin Pharmaceuticals (QNRX) and Precigen (PGEN)

TipRanksNov 14, 2023 10:10 ET

BiomX's BX004: Promising Phase 1b/2a Study Results and High Market Expectations Lead to Buy Rating

TipRanksOct 4, 2023 08:56 ET

BiomX Analyst Ratings

BenzingaAug 9, 2023 10:32 ET

Ladenburg Thalmann & Co. Remains a Buy on BiomX (PHGE)

TipRanksMay 15, 2023 12:45 ET